- Report
- April 2025
- 170 Pages
Global
From €4499EUR$4,995USD£3,970GBP
- Report
- April 2025
- 132 Pages
Global
From €3713EUR$4,123USD£3,277GBP
€4369EUR$4,850USD£3,855GBP
- Report
- March 2025
- 150 Pages
Global
From €3468EUR$3,850USD£3,060GBP
€4369EUR$4,850USD£3,855GBP
- Report
- February 2025
- 130 Pages
Global
From €3713EUR$4,123USD£3,277GBP
€4369EUR$4,850USD£3,855GBP
- Report
- July 2025
- 80 Pages
United States
From €5360EUR$5,950USD£4,729GBP
- Report
- June 2025
- 83 Pages
United States
From €5360EUR$5,950USD£4,729GBP
- Report
- July 2025
- 122 Pages
United States
From €3242EUR$3,599USD£2,861GBP
- Report
- August 2025
- 146 Pages
Asia Pacific
From €3242EUR$3,599USD£2,861GBP
- Report
- August 2025
- 102 Pages
Europe, Africa, Middle East Europe, Africa, Middle East
From €3242EUR$3,599USD£2,861GBP
- Report
- August 2025
- 121 Pages
Latin America
From €3242EUR$3,599USD£2,861GBP
- Report
- August 2025
- 113 Pages
North America
From €3242EUR$3,599USD£2,861GBP
- Report
- November 2025
Middle East
From €1887EUR$2,095USD£1,665GBP
€3594EUR$3,990USD£3,171GBP
- Report
- November 2025
Asia Pacific
From €1887EUR$2,095USD£1,665GBP
€3594EUR$3,990USD£3,171GBP
- Report
- November 2025
United States
From €1887EUR$2,095USD£1,665GBP
€3594EUR$3,990USD£3,171GBP
- Report
- November 2025
- 67 Pages
United States
From €1216EUR$1,350USD£1,073GBP
- Report
- November 2025
- 150 Pages
Europe
From €1711EUR$1,900USD£1,510GBP
- Report
- December 2024
- 199 Pages
United States
From €4999EUR$5,550USD£4,411GBP
- Report
- April 2024
- 318 Pages
Global
From €5103EUR$5,863USD£4,350GBP
- Newsletter
- November 2025
- 8 Pages
China
From €2837EUR$3,149USD£2,503GBP
- Report
- August 2025
- 115 Pages
India
From €2296EUR$2,549USD£2,026GBP
€2701EUR$2,999USD£2,384GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more